UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Recruitment of the Earliest Component of the Bacterial Flagellum to the Old Cell Division Pole by a Membrane-Associated Signal Recognition Particle Family GTP-Binding Protein

Journal of molecular biology, 2009-08, Vol.391 (4), p.679-690

2009

Link zum Volltext

Verfügbarkeit prüfen

Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing

Current oncology (Toronto), 2022-11, Vol.29 (11), p.8686-8692

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy

Current oncology (Toronto), 2023-05, Vol.30 (6), p.5299-5308

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world

Cancer medicine (Malden, MA), 2022-01, Vol.11 (1), p.86-93

2022

Link zum Volltext

Verfügbarkeit prüfen

Cell Death and Mechanoprotection by Filamin A in Connective Tissues after Challenge by Applied Tensile Forces

The Journal of biological chemistry, 2002-06, Vol.277 (24), p.21998-22009

2002

Link zum Volltext

Verfügbarkeit prüfen

Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

Clinical cancer research, 2021-01, Vol.27 (1), p.202-212

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular testing in non-small cell lung cancer: a snapshot of The Royal Free London NHS Foundation Trust experience

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S38

2021

Link zum Volltext

Verfügbarkeit prüfen

The efficacy of crizotinib in patients with -positive nonsmall cell lung cancer

Therapeutic advances in respiratory disease, 2015-06, Vol.9

2015

Link zum Volltext

Verfügbarkeit prüfen

Confirmation of germline variants identified by tumor testing: A population-based study

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e13021-e13021

2019

Link zum Volltext

Verfügbarkeit prüfen

Lung Cancer in Canada

Journal of thoracic oncology, 2019-07, Vol.14 (7), p.1128-1133

2019

Link zum Volltext

Verfügbarkeit prüfen

An audit of the management of Staphylococcus aureus bloodstream infections over two years in a District General Hospital in the United Kingdom: Category: Clinical lesson

The Journal of infection, 2011-12, Vol.63 (6), p.e78-e78

2011

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral heterogeneity in programmed death‐ligand 1 immunoreactivity is associated with variation in non‐small cell lung carcinoma histotype

Histopathology, 2020-02, Vol.76 (3), p.394-403

2020

Link zum Volltext

Verfügbarkeit prüfen

Olaratumab for the treatment of soft-tissue sarcoma

Future oncology (London, England), 2017-10, Vol.13 (24), p.2151-2157

2017

Link zum Volltext

Verfügbarkeit prüfen

Quantification of circulating free and circulating tumor DNA in pretreated EGFR mutant NSCLC to inform patient outcomes

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9080-9080

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1647: CAPTIV-8: A prospective trial of atezolizumab using a multivariate model incorporating whole genome and transcriptome analysis

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1647-1647

2021

Link zum Volltext

Verfügbarkeit prüfen

The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer

Therapeutic Advances in Respiratory Disease, 2015-06, Vol.9 (3), p.97-104

2015

Link zum Volltext

Verfügbarkeit prüfen

The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space

The Journal of molecular diagnostics : JMD, 2022-06, Vol.24 (6), p.609-618

2022

Link zum Volltext

Verfügbarkeit prüfen

Imaging-Guided Palliative Procedures: Tendon and Bursa Injection

Interventional Radiology in Palliative Care, p.59-70

Link zum Volltext

Verfügbarkeit prüfen

EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomes

Translational lung cancer research, 2020-08, Vol.9 (4), p.1084-1092

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2408: A novel multiplex droplet digital PCR approach to KRAS mutation detection in circulating tumor DNA

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2408-2408

2015

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous EGFR mutation detection and copy number assessment in circulating tumour DNA (ctDNA) to inform molecular methods of therapy resistance and plasma ctDNA content in lung adenocarcinoma

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e23027-e23027

2016

Link zum Volltext

Verfügbarkeit prüfen

Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma

Medical oncology (Northwood, London, England), 2018-10, Vol.35 (10), p.131-5, Article 131

2018

Link zum Volltext

Verfügbarkeit prüfen

Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood

Immunotherapy advances, 2023-01, Vol.3 (1), p.ltad001-ltad001

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(27)
Buchkapitel
(3)

Sprache

Englisch
(30)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Humans
(11)
Oncology
(9)
Chemotherapy
(4)
Immunotherapy
(4)
Mutation
(4)
Adult
(3)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(3)
Lung Cancer
(3)
Male
(3)
Pathology
(3)
Respiratory System
(3)
Retrospective Studies
(3)
Treatment Outcome
(3)
Animals
(2)
Apoptosis
(2)
B7-H1 Antigen - Metabolism
(2)
Biochemistry & Molecular Biology
(2)
Canada
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Recruitment of the Earliest Component of the Bacterial Flagellum to the Old Cell Division Pole by a Membrane-Associated Signal Recognition Particle Family GTP-Binding Protein

Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing

Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy

Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world

Cell Death and Mechanoprotection by Filamin A in Connective Tissues after Challenge by Applied Tensile Forces

Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

Molecular testing in non-small cell lung cancer: a snapshot of The Royal Free London NHS Foundation Trust experience

The efficacy of crizotinib in patients with -positive nonsmall cell lung cancer

Confirmation of germline variants identified by tumor testing: A population-based study

Lung Cancer in Canada

An audit of the management of Staphylococcus aureus bloodstream infections over two years in a District General Hospital in the United Kingdom: Category: Clinical lesson

Intratumoral heterogeneity in programmed death‐ligand 1 immunoreactivity is associated with variation in non‐small cell lung carcinoma histotype

International Interlaboratory Digital PCR Study Demonstrating High Reproducibility for the Measurement of a Rare Sequence Variant

Olaratumab for the treatment of soft-tissue sarcoma

Quantification of circulating free and circulating tumor DNA in pretreated EGFR mutant NSCLC to inform patient outcomes

Abstract 1647: CAPTIV-8: A prospective trial of atezolizumab using a multivariate model incorporating whole genome and transcriptome analysis

The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer

The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space

Imaging-Guided Palliative Procedures: Tendon and Bursa Injection

EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomes

Abstract 2408: A novel multiplex droplet digital PCR approach to KRAS mutation detection in circulating tumor DNA

Simultaneous EGFR mutation detection and copy number assessment in circulating tumour DNA (ctDNA) to inform molecular methods of therapy resistance and plasma ctDNA content in lung adenocarcinoma

Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience

Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood

Aktive Filter

Suchergebnisse filtern